Trastuzumab deruxtecan

AUG 19, 2026 · OBSERVATIONAL STUDY

DESTINY Breast Respond HER2-(Ultra)Low Europe

ClinicalTrials.gov

This is a registry record for an ongoing observational study with no results reported; it describes a planned real-world evidence collection in HER2-low breast cancer but cannot yet support clinical conclusions.

AUG 18, 2026 · PHASE 2 TRIAL

A Single Arm Phase 2 Study to Evaluate Efficacy and Safety of Trastuzumab Deruxtecan for Patients With HER2 Mutant NSCLC

ClinicalTrials.gov

This is a clinical trial registry record describing a planned or active Phase 2 single-arm study with no results posted; it documents design and enrollment only.

AUG 11, 2026 · PHASE 3 TRIAL

A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast Cancer

ClinicalTrials.gov

This is a Phase 3 trial registry record with no results posted; it describes planned enrollment and primary endpoints but carries no efficacy or safety data.

AUG 11, 2026 · PHASE 3 TRIAL

Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer

ClinicalTrials.gov

Phase 3 trial in active recruitment with no results posted; this registry record describes a planned study design and endpoints only, not outcomes.

AUG 3, 2026 · PHASE 1 TRIAL

A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer

ClinicalTrials.gov

This is a Phase 1b registry record with no posted results; it describes a planned safety and tolerability study of combination therapies in HER2-low metastatic breast cancer with no efficacy data yet reported.